Liraglutide received NICE approval (TA664) in 2020 for use through specialist weight management services, but the criteria are narrow, and availability has been limited in practice
Mounjaro and Zepbound contain tirzepatide, which targets two hormones instead of one, potentially producing stronger appetite suppression and greater weight loss for people who have plateaued on semaglutide alone
Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway
I've Lost Weight I'd be lying if I said I didn't take semaglutide to lose weight
You may experience extended fullness, nausea, bloating, or heartburn
As a reminder, Zepbound's label [uspl.lilly.com] contains a boxed warning regarding potential risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of MTC or in patients with multiple endocrine neoplasia syndrome type 2